Text-messaging to promote smoking cessation among individuals with opioid use disorder: quantitative and qualitative evaluation

被引：0
|
作者：
Divya Shankar
Belinda Borrelli
Vinson Cobb
Lisa M. Quintiliani
Tibor Palfai
Zoe Weinstein
Katia Bulekova
Hasmeena Kathuria
机构：
[1] Boston University Medical Center,Pulmonary Center, Department of Medicine
[2] Boston University,Section of General Internal Medicine
[3] Henry M. Goldman School of Dental Medicine,Psychological and Brain Science
[4] Boston Medical Center and Boston University School of Medicine,Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine
[5] Boston University,Research Computing Services (RCS) group, Information Services & Technology
[6] Boston Medical Center and Boston University School of Medicine,undefined
[7] Boston University,undefined
来源：
BMC Public Health | / 22卷
关键词：
Tobacco dependence treatment; Tobacco use disorder/ therapy; Opioid use disorder; Mobile health interventions; Text messaging; Substance-related disorders; Social determinants of health;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Understanding cigarette smoking among mothers with opioid use disorder
    Wanar, Amita
    Morrison, Tierney M.
    Standish, Katherine R.
    Colson, Eve R.
    Drainoni, Mari -Lynn
    Colvin, Bryanne N.
    Safon, Cara B.
    Crowell, Lisa
    Friedman, Hayley
    Schiff, Davida M.
    Parker, Margaret G.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 150
  • [42] Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder
    Kudrich, Christopher
    Chen, Rebecca
    Meng, Yuan
    Bachi, Keren
    Hurd, Yasmin L.
    HARM REDUCTION JOURNAL, 2024, 21 (01)
  • [43] Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: A qualitative analysis
    Burgess, Amanda
    Bauer, Emily
    Gallagher, Shane
    Karstens, Brianne
    Lavoie, LeeAnna
    Ahrens, Katherine
    O'Connor, Alane
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 130
  • [44] Integrating Social Determinants of Health With Tobacco Treatment for Individuals With Opioid Use Disorder: Feasibility and Acceptability Study of Delivery Through Text Messaging
    Kathuria, Hasmeena
    Shankar, Divya
    Cobb, Vinson
    Newman, Julia
    Bulekova, Katia
    Werntz, Scott
    Borrelli, Belinda
    JMIR FORMATIVE RESEARCH, 2022, 6 (09)
  • [45] Barriers to implementation of smoking cessation support among healthcare professionals in the secondary healthcare sector: A qualitative and quantitative evaluation
    Jorgensen, Camilla Uhre
    Lokke, Anders
    Hjorth, Peter
    Pisinger, Charlotta
    Farver-Vestergaard, Ingeborg
    TOBACCO PREVENTION & CESSATION, 2024, 10
  • [46] History and Correlates of Smoking Cessation Behaviors Among Individuals With Current or Past Major Depressive Disorder Enrolled in a Smoking Cessation Trial
    Quinn, Mackenzie Hosie
    Olonoff, Matthew
    Bauer, Anna-Marika
    Fox, Erica
    Jao, Nancy
    Lubitz, Su Fen
    Leone, Frank
    Gollan, Jacqueline K.
    Schnoll, Robert
    Hitsman, Brian
    NICOTINE & TOBACCO RESEARCH, 2022, 24 (01) : 37 - 43
  • [47] Nonfatal Overdoses Among Pregnant Individuals With Opioid Use Disorder
    Charles, Jasmin E.
    Baylis, Jacob
    Smid, Marcela C.
    Cochran, Gerald
    OBSTETRICS AND GYNECOLOGY, 2023, 141 (05): : 961 - 963
  • [48] Motivations for Recovery Among Pregnant Individuals With Opioid Use Disorder
    Hafen, Kody L.
    Smid, Marcela
    Garets, Mitchell
    Machado, Annika
    White, Ashley H.
    Cochran, Gerald
    OBSTETRICS AND GYNECOLOGY, 2022, 139 : 53S - 54S
  • [49] Characterizing Cardiovascular Health Among Individuals With Opioid Use Disorder
    Murugesan, Dillon
    Martinez, Suky
    Brandt, Laura
    Koh, Won-Joon
    Jones, Jermaine
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [50] Culturally-tailored text-messaging intervention for smoking cessation in rural American Indian communities: Rationale, design, and methods (vol 15, 100363, 2019)
    Orr, M. F.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2020, 20
12345